Answers are grounded in this paper and cite their sources.
The experimental animals were divided into 4 groups: Group 1 – unchanged (intact) group; Group 2 (control group) – induced experimental model of a purulent-necrotic foot with underlying alloxan diabetes; Group 3 (comparison group) – traditional multimodal treatment (ozone therapy + Reosorbilact) in an experimental model of a diabetic purulent-necrotic foot; Group 4 (main group) – multimodal treatment of an experimental model of an alloxan-induced diabetic purulent-necrotic foot using ozone therapy and Reomannisol. No fatality was observed in rats administered a 12 mg alloxan solution. The studies were conducted on the remaining 165 rats. Food and water were given to the animals 30 minutes after taking the medications. For 3 days, blood glucose levels were assessed and biochemical processes were analyzed.
No takes yet. Share an insight, caveat, or question.
G.P. Khujamurodova (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: